Vote Scores

Home / Companies / Avadel Pharmaceuticals plc

Company · votes reported on Form N-PXname as filed

Avadel Pharmaceuticals plc

How funds and institutional managers reported voting their shares, year to 30 June 2026

Filers reporting
311year to 30 June 2026
Against management on pay
12.6%35 of 277 reporting filers
Same, by reported shares
9.4%shares reported on Form N-PX
Meetings on file
4across 3 seasons
82.6% for11.3% against6.1% other12.6% against management293 filers on say-on-pay

foragainstabstain, withhold or otheramber tick: the portion cast against management

For the year to 30 June 2026, 311 funds and managers listed Avadel Pharmaceuticals plc in their Form N-PX filings (2 meetings).

On the advisory vote on executive pay, 35 of the 277 filers that reported a position voted against management (12.6%), 6.1 percentage points above the median company on this site (6.6%). By reported shares the figure is 9.4% (median 2.9%). These are shares of the filers reporting on Form N-PX, not of all votes cast at the meeting.

Among the largest fund families, 35 voted with management on pay and 5 voted against: Northern Trust and FlexShares, American Century, Nuveen and TIAA, AllianceBernstein and Voya.

Meetings

Meeting dateSeasonFilers reportingItemsAgainst management on pay
12 Jan 2026year to 30 June 2026301512.6%
29 Jul 2025year to 30 June 2026632not reported
30 Jul 2024year to 30 June 202514533.6%
1 Aug 2023year to 30 June 20241440.0%

Meetings with 20 or more reporting filers have their own page with every item. Dates are as filers typed them; dates up to three days apart are treated as one meeting.

Say-on-pay: this company and the median

year to 30 June 2026Avadel Pharmaceuticals plcMedian company
Reporting filers voting against management12.6%6.6%
Reported shares voted against management9.4%2.9%

Among filers reporting on Form N-PX. The median is over 3,799 companies with a say-on-pay item reported by 20 or more filers.

How the largest families voted

Meeting of 12 Jan 2026: say-on-pay and each shareholder proposal that could be told apart.

FamilySay-on-pay
VanguardFor
BlackRock and iSharesFor
FidelityFor
DimensionalFor
State Street and SPDRFor
American CenturyAgainst *
Franklin TempletonFor
InvescoFor
EquitableFor
Charles SchwabFor
Nuveen and TIAAAgainst *
ProShares and ProFundsFor
John Hancock and ManulifeFor
Morgan Stanley, Eaton Vance and CalvertFor
Goldman SachsFor
PGIM and PrudentialFor
Northern Trust and FlexSharesAgainst *
SEIFor
T. Rowe PriceFor
Lincoln FinancialFor
VoyaAgainst *
First TrustFor
Russell InvestmentsFor
NationwideFor
Brighthouse FundsFor
Guggenheim and RydexFor
Columbia ThreadneedleFor
BNY MellonFor
PrincipalFor
Pacific Life fundsFor
Global XFor
Federated HermesFor
AllianceBernsteinAgainst *
DWSFor
MassMutualFor
VirtusFor
Janus HendersonFor
Neuberger BermanFor
Natixis and Loomis SaylesFor
BairdFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

By season

SeasonFilers reportingAgainst management on pay, filersBy reported sharesSay-on-pay split
year to 30 June 2024140.0%0.0%
year to 30 June 20251463.6%13.8%
year to 30 June 202631112.6%9.4%

Category mix

Share of the vote records reported for this company, by the category filers chose.

CategoryVote recordsShare
DIRECTOR ELECTIONS91839.6%
SECTION 14A SAY-ON-PAY VOTES57324.7%
CORPORATE GOVERNANCE40717.6%
EXTRAORDINARY TRANSACTIONS25210.9%
AUDIT-RELATED1355.8%
CAPITAL STRUCTURE170.7%
COMPENSATION170.7%

Questions

How did large funds vote at Avadel Pharmaceuticals plc?

For the year to 30 June 2026, 277 Form N-PX filers reported a say-on-pay vote at Avadel Pharmaceuticals plc; 35 voted against management (12.6%). The table on this page lists the position of each of the largest fund families on say-on-pay and on each shareholder proposal that could be told apart in the filings.

Were there shareholder proposals at Avadel Pharmaceuticals plc?

No proposal from security holders was reported by enough filers to be shown for the year to 30 June 2026.

Is this the meeting result?

No. The figures are shares of the funds and managers that file Form N-PX, and of the shares they reported. Holders that do not file the form (individuals, most foreign investors, insiders) are not included, so the split here can differ widely from the certified result, which Avadel Pharmaceuticals plc reports on Form 8-K.

Where does the data come from?

From Form N-PX filings on the SEC's EDGAR system, grouped by company. Filers type company names and meeting dates themselves; this site groups spellings of the same company and folds meeting dates up to three days apart. Data runs through 23 Sep 2026; the median compares 3,799 companies.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Avadel Pharmaceuticals plc, grouped by company. The name is the most common spelling among filers. Not verified by the SEC. Filings read through 23 Sep 2026; page built 26 Sep 2026.